Overview
Status
Active
Registry date
2018-11-21
Share capital
50,000.00 PLN
Registered address
Aleja Jana Pawła II 22, 00-133 Warszawa, Poland
Financials
Revenue history (in k)
Filing timeliness
4 of 6 financial statements were filed late (the longest delay 645 days for 2023).
- 202521/05/2026
- 202421/04/2026
- 202321/04/2026
- 202224/07/2023
- 202126/09/2022
- 202002/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 29.88kMedianUSD 55.24kAverageUSD 2.70m
Net profit
This companyUSD 15.28kMedianUSD -1.27kAverageUSD -92.18k
Operating costs
This companyUSD 14.33kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 932.92kMedianUSD 133.19kAverageUSD 3.03m
Industry
Public procurement
Genegoggle is the contractor in one public sector contract, worth USD 7.46k.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Jul 13, 2026 | Supply of computer equipment for GUMed. | $7,455 | Gdański Uniwersytet Medyczny |
Authorized Representatives
Paweł Dynek – Attorney-in-fact (sole)
Jakub Karol Mieczkowski – Management Board Member
Michał Sebastian Marzęcki – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Genegoggle S.a.r.l. | 1,000 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2019-01-01.
76 1600 1462 1718 7215 2000 0001- 65 1600 1462 1718 7215 2000 0005
- 92 1600 1462 1718 7215 2000 0004
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| WPD Pharmaceuticalssp. z o.o. | $90,822.78 | wpdpharmaceuticals.com | ||
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Platforma Badań Genetycznychsp. z o.o. | $28,558.39 | zdrowegeny.pl | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Omnisepticasp. z o.o. | $3,475.29 | omniseptica.com | ||
| Wavex Energysp. z o.o. | $142.33 | wavexenergy.com |
FAQ
Last updated: 2026-10-07